Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 2 (2005), Issue 9 (September)

1. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women.
   Br J Cancer, 93(5): 575-81. [Abstract] [Full-text]
2. Influence of age on cervical cancer survival in Japan.
   Jpn J Clin Oncol, 35(8): 464-9. [Abstract] [Full-text]
3. Clinicopathologic features of six cases of primary cervical lymphoma.
   Am J Obstet Gynecol, 193(3): 866-72. [Abstract] [Full-text]
4. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
   Am J Obstet Gynecol, 193(3): 668-74. [Abstract] [Full-text]
5. Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.
   Am J Obstet Gynecol, 193(3): 650-7. [Abstract] [Full-text]
6. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
   J Med Screen, 12(3): 142-9. [Abstract] [Full-text]
7. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
   J Med Screen, 12(3): 134-41. [Abstract] [Full-text]
8. Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-kappaB-dependent process in human cervical carcinoma cells.
   Cancer Lett, 229(1): 49-57. [Abstract] [Full-text]
9. HPV 16 E6 sequence variations in Indian patients with cervical neoplasia.
   Cancer Lett, 229(1): 93-9. [Abstract] [Full-text]
10. Interaction of host and viral risk factors for development of cervical carcinoma in situ.
    Int J Cancer, 117(4): 690-2. [Abstract] [Full-text]
11. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence.
    Int J Cancer, 117(4): 629-37. [Abstract] [Full-text]
12. Synergy between sexual abuse and cervical cancer in causing sexual dysfunction.
    J Sex Marital Ther, 31(5): 361-83. [Abstract] [Full-text]
13. Photodynamic therapy for cervical intraepithelial neoplasia.
    Oncology, 69(2): 110-6. [Abstract] [Full-text]
14. Risk grouping in stage IB squamous cell cervical carcinoma.
    Gynecol Oncol, 99(1): 106-12. [Abstract] [Full-text]
15. Invasive potency related to RCAS1 expression in uterine cervical cancer.
    Gynecol Oncol, 99(1): 189-98. [Abstract] [Full-text]
16. Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study.
    Gynecol Oncol, 99(1): 84-91. [Abstract] [Full-text]
17. Metachronous metastases from renal cell carcinoma to uterine cervix and vagina: case report and review of literature.
    Gynecol Oncol, 99(1): 232-5. [Abstract] [Full-text]
18. Potentiation of the radiation effect with genistein in cervical cancer cells.
    Gynecol Oncol, 99(1): 199-205. [Abstract] [Full-text]
19. The role of interstitial brachytherapy using template in locally advanced gynecological malignancies.
    Gynecol Oncol, 99(1): 169-75. [Abstract] [Full-text]
20. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Gynecol Oncol, 99(1): 176-82. [Abstract] [Full-text]
21. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients.
    Gynecol Oncol, 99(1): 26-35. [Abstract] [Full-text]
22. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
    Gynecol Oncol, 99(1): 160-8. [Abstract] [Full-text]
23. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.
    Gynecol Oncol, 99(1): 113-8. [Abstract] [Full-text]
24. Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects.
    Gynecol Oncol, 99(1): 43-9. [Abstract] [Full-text]
25. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon.
    J Med Virol, 77(3): 430-8. [Abstract] [Full-text]

© 2004-2010 Cervical Cancer Research Today. All Rights Reserved.